BioWorld Science

Aug. 9, 2002

View Archived Issues

Little or no activity for KW-2189 in advanced malignant melanoma

Read More

CpG oligodeoxynucleotides may be useful against prion infection

Read More

Measurement of BNP levels provides accurate diagnosis of CHF

Read More

Fuzeon (T-20) set for launch in 2003

Read More

FDA approval for NMP22 BladderChek test

Read More

NuGEN Technologies awarded SBIR grant for anthrax test

Read More

Lescol sNDA filed for secondary prevention of cardiovascular events in angioplasty patients

Read More

FDA approves pediatric labeling of Prevacid

Read More

Bruno to market Avanir's docosanol 10% cream in Italy

Read More

HE-2200 cleared to enter phase II in patients with elevated cholesterol

Read More

Inspire and Discovery collaborate on P2Y12 antagonist program for cardiovascular disease

Read More

Pivotal phase III trial of RSR-13 completes enrollment

Read More

Approvable letter for lercanidipine

Read More

Exelixis and Bristol-Myers Squibb extend drug discovery collaboration

Read More

AstraZeneca to provide additional information for Crestor approval

Read More

Serono and Genentech sign marketing agreement for Raptiva, formerly Xanelim

Read More

Maxim updates Ceplene third quarter progress

Read More

Novel GSK-3 inhibitors and their use in diabetes, neurodegeneration, etc.

Read More

New antiemetic compound prepared and tested at UCB

Read More

Bayer presents new PDE2 inhibitors with utility in dementia

Read More

Novel iNOS inhibitor prepared by GSK researchers

Read More

Novel HDAC inhibitors identified at Beacon

Read More